세계의 저분자 표적 암 치료 시장 보고서(2025년)

Small molecule targeted cancer therapy is a form of cancer treatment that uses low-molecular-weight compounds to specifically target cancer cell proteins or pathways, inhibiting tumor growth while minimizing harm to healthy cells. Its goal is to provide precise, effective, and personalized treatment options that enhance patient outcomes and reduce the side effects associated with conventional chemotherapy.

The primary therapy types of small molecule targeted cancer therapy include tyrosine kinase inhibitors, proteasome inhibitors, histone deacetylase inhibitors, PARP inhibitors, CDK inhibitors, BCL-2 inhibitors, mTOR inhibitors, and others. Tyrosine kinase inhibitors are targeted compounds designed to block specific enzymes involved in cancer cell growth and proliferation, offering precise therapeutic effects with reduced systemic toxicity. These therapies are applied across cancer types such as lung cancer, breast cancer, colorectal cancer, leukemia, prostate cancer, and others. They are administered via oral or intravenous routes, distributed through hospital pharmacies, retail pharmacies, online pharmacies, and direct sales, and serve key end users including hospitals, specialty clinics, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The small molecule targeted cancer therapy market research report is one of a series of new reports from The Business Research Company that provides small molecule targeted cancer therapy market statistics, including the small molecule targeted cancer therapy industry global market size, regional shares, competitors with the small molecule targeted cancer therapy market share, detailed small molecule targeted cancer therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the small molecule targeted cancer therapy industry. This small molecule targeted cancer therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The small molecule targeted cancer therapy market size has grown strongly in recent years. It will grow from $78.07 billion in 2024 to $85.35 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period was driven by an improved understanding of cancer biology, rising approvals of inhibitors, increasing cancer prevalence, early adoption of personalized medicine, and expansion of oncology clinical trials.

The small molecule targeted cancer therapy market size is expected to see strong growth in the next few years. It will grow to $120.35 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth during the forecast period is fueled by growing demand for precision oncology, rising investment in next generation inhibitors, increasing healthcare expenditure in emerging markets, greater demand for these therapies, and expanding strategic collaborations. The primary trends in the forecast period include a focus on tumor agnostic therapies, development of allosteric modulators, adoption of artificial intelligence in drug discovery, increased use of oral targeted therapies, and a shift towards combination treatment strategies.

The increasing demand for personalized medicine is expected to drive growth in the small molecule targeted therapy market. Personalized medicine is a medical approach that customizes the prevention, diagnosis, and treatment of diseases based on the unique characteristics of each patient. The rising demand for personalized medicine stems from the growing need for targeted therapies that enhance treatment effectiveness and reduce side effects. Small molecule targeted therapy plays a significant role in meeting this demand by providing treatments that are more specific, improving patient responses, minimizing adverse effects, and offering therapies tailored to an individual's genetic and molecular makeup. In February 2024, the Personalized Medicine Coalition reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from the six approvals in 2022. This growing demand is driving the expansion of the small molecule targeted therapy market.

Leading companies in the small molecule targeted cancer therapy market are focusing on innovations such as structure-based drug design to create highly selective inhibitors targeting specific oncogenic mutations. This method leverages the 3D structure of a target protein to design small molecules that bind precisely, improving drug effectiveness while reducing side effects. For example, in December 2022, Mirati Therapeutics, a US-based oncology firm, announced the FDA approval of KRAZATI (adagrasib) as a targeted therapy for adult patients with KRAS G12C-mutated advanced or metastatic non-small cell lung cancer (NSCLC) who had received at least one prior systemic therapy. This approval offers a new treatment option for patients with this difficult-to-treat mutation, addressing a major unmet need. KRAZATI works by selectively inhibiting the KRAS G12C mutant protein, which is involved in the proliferation and survival of cancer cells.

In May 2023, Gilead Sciences, a US-based biopharmaceutical company, acquired XinThera Inc. for an undisclosed amount. This acquisition aims to enhance Gilead's oncology and inflammation pipeline by incorporating XinThera's small molecule inhibitors targeting PARP1 and MK2, thus expanding its precision medicine portfolio. XinThera is a biotechnology company focused on developing small molecule therapies for oncology and immunology.

Major players in the small molecule targeted cancer therapy market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis International AG, AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., and Ipsen Biopharmaceuticals Inc.

North America was the largest region in the small molecule targeted cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in small molecule targeted cancer therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the small molecule targeted cancer therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecule targeted cancer therapy market consists of sales of novel agents, venetoclax, imatinib, olaparib, niraparib. Values in this market are 'factory gate' values, meaning the value of goods sold by the manufacturers or creators of the drugs, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market also includes related services provided by the creators of these therapies.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule Targeted Cancer Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule targeted cancer therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule targeted cancer therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The small molecule targeted cancer therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy Type: Tyrosine Kinase Inhibitors; Proteasome Inhibitors; Histone Deacetylase Inhibitors; PARP Inhibitors; CDK Inhibitors; BCL-2 Inhibitors; mTOR Inhibitors; Other Small Molecule Inhibitors
• 2) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Leukemia; Prostate Cancer; Other Cancer Types
• 3) By Mode Of Administration: Oral; Intravenous; Other Modes
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Direct Sales
• 5) By End User: Hospitals; Specialty Clinics; Research Institutes; Other End Users
• Subsegments:
• 1) By Tyrosine Kinase Inhibitors: EGFR Inhibitors; VEGFR Inhibitors; ALK Inhibitors; BCR-ABL Inhibitors; HER2 Inhibitors
• 2) By Proteasome Inhibitors: Bortezomib; Carfilzomib; Ixazomib
• 3) By Histone Deacetylase Inhibitors: Pan-Histone Deacetylase Inhibitors; Class-specific Histone Deacetylase Inhibitors
• 4) By PARP Inhibitors: Olaparib; Niraparib; Rucaparib; Talazoparib
• 5) By CDK Inhibitors: CDK4/6 Inhibitors; CDK1/2 Inhibitors; Pan-CDK Inhibitors
• 6) By BCL-2 Inhibitors: Venetoclax; Navitoclax
• 7) By mTOR Inhibitors: Rapamycin Analogs (Rapalogs); ATP-competitive mTOR Inhibitors; Dual mTOR/PI3K Inhibitors
• 8) By Other Small Molecule Inhibitors: MEK Inhibitors; PI3K Inhibitors; RAF Inhibitors
• Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.; Novartis International AG; AstraZeneca plc; Bristol-Myers Squibb Company; GlaxoSmithKline plc (GSK); Eli Lilly and Company; Takeda Pharmaceutical Company Limited; Amgen Inc.; Gilead Sciences Inc.; Boehringer Ingelheim International GmbH; Astellas Pharma Inc.; Daiichi Sankyo Company Limited; Eisai Co. Ltd.; Ipsen Biopharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule Targeted Cancer Therapy Market Characteristics

3. Small Molecule Targeted Cancer Therapy Market Trends And Strategies

4. Small Molecule Targeted Cancer Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Small Molecule Targeted Cancer Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Small Molecule Targeted Cancer Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Small Molecule Targeted Cancer Therapy Market Growth Rate Analysis
• 5.4. Global Small Molecule Targeted Cancer Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Small Molecule Targeted Cancer Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Small Molecule Targeted Cancer Therapy Total Addressable Market (TAM)

6. Small Molecule Targeted Cancer Therapy Market Segmentation

• 6.1. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tyrosine Kinase Inhibitors
• Proteasome Inhibitors
• Histone Deacetylase Inhibitors
• PARP Inhibitors
• CDK Inhibitors
• BCL-2 Inhibitors
• mTOR Inhibitors
• Other Small Molecule Inhibitors
• 6.2. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Leukemia
• Prostate Cancer
• Other Cancer Types
• 6.3. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Other Modes
• 6.4. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Direct Sales
• 6.5. Global Small Molecule Targeted Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Research Institutes
• Other End Users
• 6.6. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Tyrosine Kinase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• EGFR Inhibitors
• VEGFR Inhibitors
• ALK Inhibitors
• BCR-ABL Inhibitors
• HER2 Inhibitors
• 6.7. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Proteasome Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bortezomib
• Carfilzomib
• Ixazomib
• 6.8. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Histone Deacetylase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pan-Histone Deacetylase Inhibitors
• Class-specific Histone Deacetylase Inhibitors
• 6.9. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of PARP Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Olaparib
• Niraparib
• Rucaparib
• Talazoparib
• 6.10. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of CDK Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CDK4/6 Inhibitors
• CDK1/2 Inhibitors
• Pan-CDK Inhibitors
• 6.11. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of BCL-2 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Venetoclax
• Navitoclax
• 6.12. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of mTOR Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rapamycin Analogs (Rapalogs)
• ATP-competitive mTOR inhibitors
• Dual mTOR Or PI3K Inhibitors
• 6.13. Global Small Molecule Targeted Cancer Therapy Market, Sub-Segmentation Of Other Small Molecule Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• MEK Inhibitors
• PI3K Inhibitors
• RAF Inhibitors

7. Small Molecule Targeted Cancer Therapy Market Regional And Country Analysis

• 7.1. Global Small Molecule Targeted Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Small Molecule Targeted Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule Targeted Cancer Therapy Market

• 8.1. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule Targeted Cancer Therapy Market

• 9.1. China Small Molecule Targeted Cancer Therapy Market Overview
• 9.2. China Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule Targeted Cancer Therapy Market

• 10.1. India Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule Targeted Cancer Therapy Market

• 11.1. Japan Small Molecule Targeted Cancer Therapy Market Overview
• 11.2. Japan Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule Targeted Cancer Therapy Market

• 12.1. Australia Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule Targeted Cancer Therapy Market

• 13.1. Indonesia Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule Targeted Cancer Therapy Market

• 14.1. South Korea Small Molecule Targeted Cancer Therapy Market Overview
• 14.2. South Korea Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule Targeted Cancer Therapy Market

• 15.1. Western Europe Small Molecule Targeted Cancer Therapy Market Overview
• 15.2. Western Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule Targeted Cancer Therapy Market

• 16.1. UK Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule Targeted Cancer Therapy Market

• 17.1. Germany Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule Targeted Cancer Therapy Market

• 18.1. France Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule Targeted Cancer Therapy Market

• 19.1. Italy Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule Targeted Cancer Therapy Market

• 20.1. Spain Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule Targeted Cancer Therapy Market

• 21.1. Eastern Europe Small Molecule Targeted Cancer Therapy Market Overview
• 21.2. Eastern Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule Targeted Cancer Therapy Market

• 22.1. Russia Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule Targeted Cancer Therapy Market

• 23.1. North America Small Molecule Targeted Cancer Therapy Market Overview
• 23.2. North America Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule Targeted Cancer Therapy Market

• 24.1. USA Small Molecule Targeted Cancer Therapy Market Overview
• 24.2. USA Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule Targeted Cancer Therapy Market

• 25.1. Canada Small Molecule Targeted Cancer Therapy Market Overview
• 25.2. Canada Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule Targeted Cancer Therapy Market

• 26.1. South America Small Molecule Targeted Cancer Therapy Market Overview
• 26.2. South America Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule Targeted Cancer Therapy Market

• 27.1. Brazil Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule Targeted Cancer Therapy Market

• 28.1. Middle East Small Molecule Targeted Cancer Therapy Market Overview
• 28.2. Middle East Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule Targeted Cancer Therapy Market

• 29.1. Africa Small Molecule Targeted Cancer Therapy Market Overview
• 29.2. Africa Small Molecule Targeted Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Small Molecule Targeted Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Small Molecule Targeted Cancer Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule Targeted Cancer Therapy Market Competitive Landscape And Company Profiles

• 30.1. Small Molecule Targeted Cancer Therapy Market Competitive Landscape
• 30.2. Small Molecule Targeted Cancer Therapy Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule Targeted Cancer Therapy Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Novartis International AG
• 31.4. AstraZeneca plc
• 31.5. Bristol-Myers Squibb Company
• 31.6. GlaxoSmithKline plc (GSK)
• 31.7. Eli Lilly and Company
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Amgen Inc.
• 31.10. Gilead Sciences Inc.
• 31.11. Boehringer Ingelheim International GmbH
• 31.12. Astellas Pharma Inc.
• 31.13. Daiichi Sankyo Company Limited
• 31.14. Eisai Co. Ltd.
• 31.15. Ipsen Biopharmaceuticals Inc.

32. Global Small Molecule Targeted Cancer Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule Targeted Cancer Therapy Market

34. Recent Developments In The Small Molecule Targeted Cancer Therapy Market

35. Small Molecule Targeted Cancer Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Small Molecule Targeted Cancer Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Small Molecule Targeted Cancer Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Small Molecule Targeted Cancer Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer